These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15657753)

  • 1. [Significance of dendritic cells for the immunotherapy of tumors].
    Weise JB; Maune S; Kabelitz D; Heiser A
    HNO; 2005 Feb; 53(2):117-20. PubMed ID: 15657753
    [No Abstract]   [Full Text] [Related]  

  • 2. Dendritic cells in cancer immunotherapy. 10 January 2005, London, UK.
    George AJ
    IDrugs; 2005 Feb; 8(2):104-6. PubMed ID: 15696407
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antitumor cellular immunotherapy: the breakthrough of dendritic cells].
    Angevin E; André F; Zitvogel L
    Bull Cancer; 2000 Jan; 87(1):107-15. PubMed ID: 10673639
    [No Abstract]   [Full Text] [Related]  

  • 4. Dendritic cells and immunotherapy for malignant disease.
    Reid DC
    Br J Haematol; 2001 Mar; 112(4):874-87. PubMed ID: 11298582
    [No Abstract]   [Full Text] [Related]  

  • 5. Dendritic cell activation kinetics and cancer immunotherapy.
    Bellone M; Camporeale A; Boni A
    J Immunol; 2004 Mar; 172(5):2727-8. PubMed ID: 14978067
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic cells: a journey from laboratory to clinic.
    Cerundolo V; Hermans IF; Salio M
    Nat Immunol; 2004 Jan; 5(1):7-10. PubMed ID: 14699398
    [No Abstract]   [Full Text] [Related]  

  • 7. Current status and future applications of cellular therapies for cancer.
    Copier J; Bodman-Smith M; Dalgleish A
    Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current developments of immunotherapy in the clinic.
    Antonia S; Mulé JJ; Weber JS
    Curr Opin Immunol; 2004 Apr; 16(2):130-6. PubMed ID: 15023403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells: still a promising tool for cancer immunotherapy.
    Aragoneses-Fenoll L; Corbí AL
    Clin Transl Oncol; 2007 Feb; 9(2):77-82. PubMed ID: 17329218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adoptive immunotherapy in solid tumors: new hope].
    Jotereau F; Labarrière N; Gervois N; Pandolfino MC; Dreno B
    Med Sci (Paris); 2003 Mar; 19(3):268-70. PubMed ID: 12836404
    [No Abstract]   [Full Text] [Related]  

  • 11. An artificial solution for adoptive immunotherapy.
    Zemon H
    Trends Biotechnol; 2003 Oct; 21(10):418-20. PubMed ID: 14512224
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel perspectives on dendritic cell-based immunotherapy of cancer.
    Bonaccorsi I; Pezzino G; Morandi B; Ferlazzo G
    Immunol Lett; 2013; 155(1-2):6-10. PubMed ID: 24076312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of dendritic cell therapy for cancer: progress and challenges.
    Mantia-Smaldone GM; Chu CS
    BioDrugs; 2013 Oct; 27(5):453-68. PubMed ID: 23592406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
    Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
    Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adoptive immunotherapy: evaluation and perspectives in the treatment of certain cancers].
    Bartholeyns J; Bardot V; Chokri M; Romet-Lemonne JL
    Rev Med Interne; 2000 Oct; 21(10):863-71. PubMed ID: 11075395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
    Viaud S; Théry C; Ploix S; Tursz T; Lapierre V; Lantz O; Zitvogel L; Chaput N
    Cancer Res; 2010 Feb; 70(4):1281-5. PubMed ID: 20145139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells as adjuvants for immune-mediated resistance to tumors.
    Schuler G; Steinman RM
    J Exp Med; 1997 Oct; 186(8):1183-7. PubMed ID: 9379142
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro priming to tumor-associated proteins.
    Hand SL; Bernhard H; Huseby ES; Rubin WD; Disis ML; Cheever MA
    Adv Exp Med Biol; 1997; 417():503-9. PubMed ID: 9286411
    [No Abstract]   [Full Text] [Related]  

  • 20. Dendritic cells for the immunotherapy of cancer.
    Melcher A; Bateman A; Harrington K; Ahmed A; Gough M; Vile R
    Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):185-92. PubMed ID: 12109820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.